CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Merck, Daiichi Withdraw FDA Filing for Lung Cancer Therapy

NDA FilingNegative
AI Analysis

Summary

Merck and Daiichi Sankyo have withdrawn their FDA filing for a lung cancer therapy, a significant setback for the joint development program.

Outcome Details

Merck and Daiichi withdrew FDA filing for lung cancer therapy

Importance:7/10
Sentiment:
-0.80
FDAwithdrawaloncologypartnership
Related Companies

Read the original article

Published by yahoo_finance on September 28, 2026 3:23 PM

Read Original